Therefore, the mutation of RNF43/ZNRF3 may create a genetic dependency on APC. If true, exploiting the dependency on APC, a canonical tumor suppressor gene, may be a novel therapeutic treatment for patients with an RNF43 mutated cancer. This evidence concerns the gene APC and cancer.